Overview

Pattern Biosciences provides an in-vitro diagnostics platform that speeds up bacterial identification and antibiotic susceptibility testing. It uses single-cell analysis combined with machine learning on patient samples via an instrument and proprietary test kits to determine the most effective antibiotic within hours. The company differentiates itself by delivering rapid, actionable results through integrated single-cell data and ML, with a recurring revenue model from selling instruments and consumables to hospitals and labs. Its goal is to improve patient outcomes, reduce healthcare costs, and help preserve existing antibiotics by enabling faster, more accurate treatment choices for severe infections.

Significant Headcount Growth